Anterix Inc. filings document the company’s 900 MHz private wireless broadband spectrum business, including material-event reports on spectrum license sale agreements, operating and financial results, Regulation FD updates, and capital-structure disclosures. The records include disclosures tied to broadband license sales, narrowband-to-broadband license exchanges, spectrum clearing costs, contracted proceeds, and the Demonstrated Intent key performance indicator.
The company’s SEC filings also cover governance matters, executive compensation and severance arrangements, shareholder voting matters, risk factors, and regulatory developments affecting broadband use of the 900 MHz band. Material agreements involving its wholly owned subsidiary, PDV Spectrum Holding Company, LLC, are documented through Form 8-K exhibits and related event disclosures.
ALTMAN JEFFREY A reported acquisition or exercise transactions in this Form 4 filing.
Anterix Inc. director and ten percent owner Jeffrey A. Altman reported a grant of 1,598 shares of common stock on August 4, 2026 as compensation for his services as a non-employee director. The award will vest on the earlier of the 2027 annual shareholder meeting and August 4, 2027 under a Restricted Stock Agreement.
After this grant, Altman reported 124,492 shares of common stock held directly and 5,411,776 shares held indirectly through Owl Creek funds advised by Owl Creek Asset Management, L.P. Altman and the investment manager each disclaim beneficial ownership beyond their pecuniary interests in these securities.
YAZDI MAHVASH reported acquisition or exercise transactions in this Form 4 filing.
Anterix Inc. director Mahvash Yazdi received a grant of 1,598 shares of common stock on August 4, 2026, as a restricted stock award at $0.00 per share. These shares vest on the earlier of the 2027 annual shareholder meeting or August 4, 2027. Following the grant, she directly holds 21,005 shares, with additional indirect holdings of 250 shares through a family trust, where she disclaims beneficial ownership beyond her pecuniary interest, and 750 shares through a 401(k) plan. The transaction is reported as not pursuant to a Rule 10b5-1 trading plan.
Fleischhauer Mark reported acquisition or exercise transactions in this Form 4 filing.
Anterix Inc. director Mark Fleischhauer received a grant of 1,598 shares of common stock as a stock award. The shares vest on the earlier of the company’s 2027 Annual Meeting of shareholders and August 4, 2027, under a Restricted Stock Agreement, bringing his direct holdings to 14,367 shares.
Anterix Inc. director Leslie B. Daniels reported receiving a grant of 1,598 shares of common stock on August 4, 2026 as a restricted stock award. These shares will vest on the earlier of the 2027 Annual Meeting of shareholders and August 4, 2027, under a Restricted Stock Agreement.
Following this award, Daniels directly holds 56,077 Anterix shares, with additional indirect holdings of 2,000 shares by IRA and 5,000 shares by 401K. The award is a compensation-related acquisition and was not designated as made under a Rule 10b5-1 trading plan.
BlackRock, Inc. reports beneficial ownership of common stock of Antarix Inc. on a Schedule 13G. BlackRock indicates beneficial ownership of 999,278 shares of Antarex common stock, representing 5.1% of the class as of the reporting date.
BlackRock has sole voting power over 986,208 shares and sole dispositive power over 999,278 shares, with no shared voting or dispositive power. Various underlying clients have rights to dividends or sale proceeds, but no individual person is reported to hold more than five percent of Antarex’s outstanding common shares through these arrangements.
Anterix Inc. Chief Financial Officer Elena Marquez reported a tax-related share disposition. On 2026-07-13, 231 shares of common stock were withheld by the issuer at $100.96 per share to satisfy withholding obligations tied to partial vesting and settlement of restricted stock units. Following this non-market, tax-withholding disposition, Marquez holds 18,156 shares of Anterix common stock directly.
Anterix Inc. Chief Reg & Comm Officer Christopher Guttman-McCabe reported a Form 4 transaction involving a tax-withholding disposition of 1,516 shares of common stock at $100.96 per share on July 13, 2026. The shares were withheld by the company to satisfy withholding obligations related to the partial vesting and settlement of restricted stock units. After this withholding, he directly holds 76,291 shares of Anterix common stock.
Anterix Inc. executive Christopher Guttman-McCabe updated his reported stock option holdings to correct a previously misreported balance. The amended disclosure shows a fully vested stock option to purchase 50,876 shares of common stock at an exercise price of $34.40 per share, expiring on October 21, 2030. No new option grants, exercises, sales, or other transactions are reported; only the number of securities held was corrected.
Owl Creek Asset Management and Jeffrey A. Altman updated their ownership reporting in Anterix Inc. following an increase in shares outstanding. Owl Creek reports beneficial ownership of 5,411,776 shares, or 27.7% of Anterix common stock. Altman reports beneficial ownership of 5,551,684 shares, or 28.5% of the class.
The filing states that these ownership percentages declined solely because Anterix’s outstanding shares rose to 19,506,240, including 7,767 shares underlying unvested restricted stock awards. Altman holds 15,416 vested and unvested restricted stock awards and 124,492 shares directly, with no common stock transactions by the reporting persons in the past 60 days.
ANTERIX INC 13G filing shows T. Rowe Price Investment Management, Inc. reports beneficial ownership of 2,348,019 shares, representing 12.0% of outstanding common stock as of 06/30/2026. The filing includes declarations that beneficial ownership is denied by the filer and is signed by a Vice President on 07/08/2026.